Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Can J Microbiol ; 46(2): 180-7, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10721487

RESUMEN

Both the moderately halophilic bacterium, Halomonas elongata, and the extremely halophilic archaea, Halobacterium salinarum, can be found in hypersaline environments (e.g., salterns). On complex media, H. elongata grows over a salt range of 0.05-5.2 M, whereas, H. salinarum multiplies over a salt range of 2.5-5.2 M. The purpose of this study was to illustrate the effect that solar (UV-A and UV-B) and germicidal radiation (UV-C) had on the growth patterns of these bacteria at varied salt concentrations. Halomonas elongata grown on a complex medium at 0.05, 1.37, and 4.3 M NaCl was found to be more sensitive to UV-A and UV-B radiation, as the salt concentration of the medium increased. Halobacterium salinarum grown on a complex medium at 3.0 and 4.3 M NaCl did not show a significant drop in viability after 39.3 kJ.m-2 of UV-A and UV-B exposure. When exposed to UV-C, H. elongata exhibited substantially more sensitivity than H. salinarum. In H. elongata, differential sensitivity to UV-C was observed. At 0.05 M NaCl, H. elongata was less sensitive to UV-C than at 1.37 and 4.3 M NaCl. Both bacteria showed some photoreactivation when incubated under visible light following both UV-A, UV-B, and UV-C exposure. Mutagenesis following UV-C exposure was demonstrated by both organisms.


Asunto(s)
Halobacterium salinarum/efectos de la radiación , Halomonas/efectos de la radiación , Rayos Ultravioleta , Antibacterianos/farmacología , Reparación del ADN , Farmacorresistencia Microbiana , Halobacterium salinarum/efectos de los fármacos , Halobacterium salinarum/crecimiento & desarrollo , Halomonas/efectos de los fármacos , Halomonas/crecimiento & desarrollo , Mutagénesis , Novobiocina/farmacología , Rifampin/farmacología , Cloruro de Sodio/farmacología
2.
J Immunol ; 157(5): 2168-73, 1996 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-8757343

RESUMEN

The Ab-dependent cell-mediated cytotoxicity (ADCC) activity of anti-gp120 Abs in serum from four groups of HIV-1-positive individuals in the Multicenter AIDS Cohort Study was evaluated at several time points over a 10-yr period. HIV-1-positive individuals who progressed to AIDS within 3 yr of seroconversion (rapid progressors) were compared with seroconverters who did not progress to AIDS within 6 yr (nonrapid progressors) and individuals who were seropositive when they entered the study and did not progress to AIDS within 9-10 yr (nonprogressors). At the visit closest to AIDS, rapid progressors had significantly lower titers of Abs that mediate ADCC against HIV-1 gp120 than those of nonrapid progressors at corresponding visits or those of nonprogressors at any visit. Nonprogressors generally had high titers of ADCC Abs at all visits. Differences between ADCC titers of rapid progressors and nonrapid progressors or nonprogressors remained when longitudinal changes within individuals were compared. Among seroconverters who were nonrapid progressors, those with low or declining ADCC titers lost significantly more CD4+ cells during the study than those whose ADCC titers were stable or increasing, even though both groups had similar serum virion RNA levels. This demonstrates that high titers of Abs that mediate ADCC correlate with a successful host defense against AIDS.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/inmunología , Anticuerpos Antivirales/fisiología , Citotoxicidad Celular Dependiente de Anticuerpos , Proteína gp120 de Envoltorio del VIH/inmunología , VIH-1/inmunología , Síndrome de Inmunodeficiencia Adquirida/epidemiología , Pruebas Inmunológicas de Citotoxicidad , Progresión de la Enfermedad , Proteína gp120 de Envoltorio del VIH/sangre , Seropositividad para VIH/epidemiología , Seropositividad para VIH/inmunología , Seropositividad para VIH/virología , Seroprevalencia de VIH , Humanos , Masculino , Estudios Prospectivos , Estudios Retrospectivos , Viremia/epidemiología , Viremia/inmunología
3.
Cell Immunol ; 155(2): 457-75, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-8181076

RESUMEN

C-reactive protein (CRP), an acute phase protein in human serum, is present on large granular lymphocytes (LGL). Anti-CRP inhibits natural killer (NK) cell-mediated lysis. Our current study shows that anti-CRP also inhibits antibody-dependent cell-mediated cytotoxicity (ADCC) of LGL. Calcium influx and protein kinase C (PKC) activation are the early signal transduction events in NK activation. In the conjugates formed between LGL and targets (NK or ADCC), 75-90% of LGL respond with a calcium influx. Addition of anti-CRP had no effect on the percentage of LGL which respond to target cell binding or on the magnitude of the calcium response of LGL. This was true for both NK and ADCC effector cells. Crosslinking anti-CRP with a secondary antibody did not alter this result. Next, the effect of PMA, a PKC activator, and calcium ionophore, A23187, on anti-CRP-mediated inhibition of cytotoxicity were studied. PMA alone reversed most of the inhibition of lysis seen with anti-CRP. Based on previous observations that anti-CRP inhibited target cell-stimulated release of lytic factors, the effect of anti-CRP on release of lytic factors stimulated by PMA and calcium ionophore was evaluated. Anti-CRP blocked the release of lytic factors stimulated by PMA and ionophore. Release of lytic factors involves the rearrangement of cytoskeletal element of NK cell toward the target cell. The effect of anti-CRP on cytoskeletal reorganization was studied. In conjugates formed between effector and target cells, the polarization of cytoskeleton at the contact site of NK and target cell was significantly reduced in the presence of anti-CRP. Although anti-CRP inhibits both ADCC and NK lytic mechanisms, it does not alter target cell-induced Ca2+ influx. CRP interacts with the secretory mechanisms involved in granule exocytosis since anti-CRP inhibits the cytoskeletal polarization and the release of lytic factors and PMA might reverse anti-CRP-mediated inhibition by activating alternative mechanisms of cytotoxicity in effectors.


Asunto(s)
Citotoxicidad Celular Dependiente de Anticuerpos/inmunología , Proteína C-Reactiva/metabolismo , Células Asesinas Naturales/inmunología , Activación de Linfocitos , Transducción de Señal , Proteína C-Reactiva/inmunología , Calcio/metabolismo , Polaridad Celular , Reactivos de Enlaces Cruzados , Citoesqueleto/ultraestructura , Granulocitos , Humanos , Inmunoglobulina G/farmacología , Factores Asesinos de Levadura , Proteínas/metabolismo , Acetato de Tetradecanoilforbol/farmacología
4.
J Immunol ; 146(8): 2873-8, 1991 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-2016530

RESUMEN

The studies described in this publication were designed to determine which stage of the NK lytic mechanism is inhibited by anti-C-reactive protein (CRP). Although anti-CRP prevents target cell lysis, it does not block E:T cell conjugate formation. In parallel experiments, the number of conjugates observed in the presence of anti-CRP was normal, whereas the number of target cells killed by this same group of effector cells was greatly inhibited. Since an early stage of NK-mediated lysis requires calcium, conjugates can be synchronized by incubating effector and target cells in the absence of calcium. When conjugates were formed in the absence of calcium, and anti-CRP and calcium were then added to cultures at the same time, anti-CRP inhibited maximally. Anti-CRP continued to inhibit somewhat throughout the calcium-dependent stage but did not block lysis when added after the completion of calcium requiring events. Events that are blocked by anti-CRP must be required for the generation of NK cytotoxic factor because anti-CRP blocks the production of this factor. Once generated, however, anti-CRP does not block the activity of NK cytotoxic factor. This evidence indicates that anti-CRP blocks NK-mediated lysis at the calcium dependent stage of lysis. Events that follow this stage in the lytic process are also inhibited.


Asunto(s)
Proteína C-Reactiva/fisiología , Células Asesinas Naturales/fisiología , Activación de Linfocitos/fisiología , Anticuerpos Monoclonales/farmacología , Calcio/fisiología , Citotoxicidad Inmunológica/fisiología , Humanos , Técnicas In Vitro
5.
J Exp Med ; 173(2): 495-8, 1991 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-1988544

RESUMEN

We synthesized and cloned cDNA from human peripheral blood mononuclear cell (PBMC) transcripts that were hybrid selected by pCRP5, a liver C-reactive protein (CRP)-specific cDNA (Woo, P.,J.R. Korenberg, and A.S. Whitehead. 1985. J.Biol. Chem. 260:13384). Three hybrid-selected cDNA clones, HScDNA1, HScDNA3, and HScDNA8, were isolated and characterized. Nucleotide sequence analysis of the 5' end of the smaller clones, HScDNA1 and HScDNA8, demonstrated that these two PBMC clones are homologous to the 3' and 5' ends, respectively, of pCRP5. Our largest clone, HScDNA3, is larger than pCRP5, extending beyond both the 5' and 3' limits of pCRP5. Therefore, HScDNA3 was coded by human PBMC and not by the hybrid selection vehicle, pCRP5. HScDNA3 lacks the intervening sequence verifying that this clone is DNA made from a PBMC mRNA and not genomic DNA. The complete nucleotide sequence revealed that HScDNA3 is greater than 99% homologous to the CRP gene. These results demonstrate that PBMC express the CRP gene. Based on our previous report, which shows that peripheral blood cells synthesize a peptide recognized by anti-CRP (Kuta, A.E., and L.L. Baum. 1986. J. Exp. Med. 164:321), in conjunction with the data presented here, we conclude that human PBMC can synthesize CRP.


Asunto(s)
Proteína C-Reactiva/genética , Leucocitos Mononucleares/metabolismo , Transcripción Genética , Secuencia de Bases , Proteína C-Reactiva/biosíntesis , Clonación Molecular , ADN , Humanos , Datos de Secuencia Molecular , ARN Mensajero/biosíntesis , Homología de Secuencia de Ácido Nucleico
6.
J Immunol ; 139(9): 3107-11, 1987 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-2444651

RESUMEN

The recent development of a method for culturing the parasitic form of Coccidioides immitis by using conditions compatible with the growth of lymphoid cells has enabled us to investigate the role of natural killer (NK) cells in defense against this pathogenic fungus. Pure cultures of spherules and endospores were grown in RPMI 1640 which contained 10% calf serum. Single cell suspensions of young spherules and endospores were incubated in the presence of freshly isolated human peripheral blood lymphocytes (PBL). After a 4-hr incubation, the colony-forming ability of the fungus was significantly reduced. Leu-11 is a monoclonal antibody that binds to the Fc receptor of NK cells. When PBL were incubated in the presence of this monoclonal antibody and complement, the colony-forming ability of C. immitis was not reduced, indicating that the effector cell involved in reduction of colony-forming units is also recognized by the Leu-11 monoclonal antibody. Classical NK activity can be enhanced by preincubation with interferon; the inhibitory activity of the PBL which are responsible for the reduction in colony-forming units of C. immitis is similarly enhanced by pretreatment with interferon. When PBL are incubated in the presence of young spherules and endospores for 24 hr, the cellfree supernatants will kill U937 target cells. In addition to stimulating the release of NK cytotoxic factor, C. immitis is susceptible to inactivation when incubated in the presence of factors released by PBL which have been incubated in the presence of either K562 or C. immitis. Other evidence reported by this laboratory demonstrates that C-reactive protein is present on the surface of NK cells and that antibody to this molecule blocks NK-mediated killing of standard tumor cell targets. Pretreatment with anti-C-reactive protein also blocks the ability of PBL to inhibit the colony-forming capacity of this fungus. These data suggest that the cell that inhibits the in vitro growth of the pathogenic fungus, C. immitis, is an NK cell.


Asunto(s)
Coccidioides/inmunología , Células Asesinas Naturales/inmunología , Anticuerpos Monoclonales , Proteína C-Reactiva/fisiología , Citotoxicidad Inmunológica , Citotoxinas/biosíntesis , Humanos , Inmunidad Celular , Técnicas In Vitro , Interferones/farmacología
7.
Immunology ; 61(1): 93-9, 1987 May.
Artículo en Inglés | MEDLINE | ID: mdl-3583316

RESUMEN

Anti-CRP and complement treatment of human peripheral blood lymphocytes significantly reduces natural killer (NK) cell-mediated cytotoxicity to K562 target cells as well as to MOLT-4 target cells. Although not all activity is eliminated by treatment of effector cells with antibody and complement, the reduction of NK function indicates that C-reactive protein (CRP) is present on a significant proportion of NK cells. Higher concentrations of anti-CRP or anti-CRP F(ab')2 fragments also reduce NK function; this suggests that CRP is not only present on these effector cells but may also play a role in NK-mediated killing. We initially suspected that CRP-ligand interactions might be involved in effector-target cell recognition. Several lines of evidence suggest that this is not the case. While F(ab')2 anti-CRP will block NK function, Fab anti-CRP will not, suggesting that the NK response is not impaired when surface CRP (S-CRP) is blocked but is only inhibited when the S-CRP is cross-linked and modulated. Neither CRP-C polysaccharide complexes (CRP-CPS) nor concentrations of CPS ranging from 0.1 microgram/ml to 200 micrograms/ml have any effect on NK cell-mediated killing. Treatment of target cells with a ligand for CRP or CRP prior to co-culture with NK effectors does not augment NK function. Single cell assays clearly demonstrate that high concentrations of anti-CRP have no effect on the formation of effector-target cell conjugates. Although these concentrations of anti-CRP do not block effector-target cell conjugation in the single cell assay, they do block the killing of conjugated target cells. In total, this evidence strongly suggests that although CRP appears to be involved in NK-mediated killing, it is not involved in effector-target cell-mediated recognition.


Asunto(s)
Proteína C-Reactiva/fisiología , Citotoxicidad Inmunológica , Células Asesinas Naturales/inmunología , Anticuerpos/inmunología , Proteína C-Reactiva/inmunología , Línea Celular , Proteínas del Sistema Complemento/inmunología , Humanos , Fragmentos Fab de Inmunoglobulinas/inmunología , Neoplasias Experimentales/inmunología , Polisacáridos Bacterianos/farmacología , Protaminas/farmacología
8.
J Exp Med ; 164(1): 321-6, 1986 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-3723078

RESUMEN

Biosynthetic labeling with [35S]met and immunoprecipitation with anti-C-reactive protein (CRP) antibodies and Staphylococcus aureus indicate that cell surface CRP is produced by lymphocytes. The ability of anti-CRP to reduce NK activity, and the demonstration that 125I-anti-CRP-labeled PBL are found in low-density Percoll fractions associated with large granular lymphocyte (LGL) and NK activity suggest that S-CRP-bearing cells are NK effectors. The production of S-CRP by LGL supports this hypothesis. While lymphocytes were shown to synthesize S-CRP, monocytes produced no detectable S-CRP. The lymphocytes that produce S-CRP apparently do not secrete it; when lymphocyte culture supernatants were tested, no S-CRP was found. This is the first description of extrahepatic synthesis of CRP.


Asunto(s)
Proteína C-Reactiva/biosíntesis , Linfocitos/metabolismo , Sitios de Unión de Anticuerpos , Unión Competitiva , Proteína C-Reactiva/inmunología , Proteína C-Reactiva/metabolismo , Calcio/farmacología , Humanos , Sueros Inmunes/farmacología , Células Asesinas Naturales/metabolismo , Proteínas de la Membrana/biosíntesis , Proteínas de la Membrana/sangre
9.
J Leukoc Biol ; 39(1): 13-25, 1986 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-3455709

RESUMEN

C-reactive protein (CRP) is a trace serum protein that increases markedly in concentration during inflammatory reactions. Although CRP, in the presence of a multivalent ligand, binds in vitro to a small percentage of peripheral blood lymphocytes from normal donors and is present on natural killer (NK) cells, exogenous addition of CRP has few effects on human lymphocytes. CRP causes minimal enhancement of proliferation in a mixed lymphocyte culture and a slight increase in 3H-thymidine uptake by unstimulated cells. The most significant effect of CRP is a substantial increase in cell-mediated cytotoxicity (CMC). In this publication, we show that CRP dramatically enhances the alloantigen-activated cytotoxic response only when it is present at the initiation of culture and that pretreatment of responder cells with CRP will not produce enhancement. Although the CMC enhancement generated the presence of CRP is not antigen specific, it is mediated by a T cell, and neither NK-like cells nor monocytes are involved in mediating CRP enhanced killing.


Asunto(s)
Proteína C-Reactiva/inmunología , Inmunidad Celular , Linfocitos/inmunología , Animales , Proteína C-Reactiva/aislamiento & purificación , Células Cultivadas , Citotoxicidad Inmunológica , Replicación del ADN , Humanos , Células Asesinas Naturales/inmunología , Activación de Linfocitos , Ratones
10.
J Clin Microbiol ; 22(2): 165-7, 1985 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3897262

RESUMEN

Investigation of host-parasite relationships involving the parasitic form of Coccidioides immitis has been difficult because, previously, spherules and endospores have not been grown continuously in tissue culture medium without detectable formation of hyphae. Arthroconidia were harvested from mycelial cultures and inoculated into tissue culture flasks which contained RPMI 1640 medium supplemented with 10% calf serum and N-Tamol (Rohm & Haas Co., Philadelphia, Pa.). Flasks were purged with 5% CO2, sealed, and placed on a reciprocating shaker at 35 degrees C. Hyphae which arose during incubation were removed by filtration. Arthroconidia readily converted to the spherule-endospore form within 12 days. Six days after complete conversion, spherules and endospores were transferred to RPMI 1640 without N-Tamol. The spherule-endospore cycle was maintained in tissue culture medium for 84 days without the formation of detectable hyphae.


Asunto(s)
Coccidioides/crecimiento & desarrollo , Coccidioides/citología , Coccidioides/aislamiento & purificación , Medios de Cultivo , Humanos , Técnicas Microbiológicas , Esporas Bacterianas/citología , Esporas Bacterianas/crecimiento & desarrollo , Factores de Tiempo
11.
Infect Immun ; 48(2): 446-51, 1985 May.
Artículo en Inglés | MEDLINE | ID: mdl-3988342

RESUMEN

In vitro phagocytosis and intracellular survival of Campylobacter jejuni strain 2964 in mononuclear phagocytes were studied. The following three types of mononuclear phagocytes were used: a J774G8 peritoneal macrophage line derived from BALB/c mice, resident BALB/c peritoneal macrophages, and human peripheral blood monocytes. When C. jejuni and mononuclear phagocytes were combined at a ratio of 75:1, light microscopy, fluorescent microscopy, and electron microscopy all indicated that C. jejuni cells were readily phagocytized. The majority of C. jejuni cells were spirals immediately following ingestion and were rapidly converted to the coccal form within 4 to 8 h. Conversion from the spiral form to the coccal form was complete in the presence of phagocytes within 96 h. In control preparations without phagocytes, conversion began after 24 h and was complete after 48 h. The extent of phagocytosis over time was determined by observing Giemsa-stained preparations and counting the number of intracellular bacterial colony-forming units after removal of extracellular C. jejuni. Human monocytes ingested C. jejuni more rapidly and vigorously than murine macrophages. Intracellular survival of C. jejuni was examined by measuring the number of C. jejuni colony-forming units associated with phagocytes after phagocytosis for 2 h and removal of extracellular bacteria. C. jejuni survived intracellularly for up to 6 to 7 days.


Asunto(s)
Campylobacter fetus/fisiología , Macrófagos/microbiología , Monocitos/microbiología , Fagocitosis , Animales , Campylobacter fetus/citología , Campylobacter fetus/inmunología , Línea Celular , Humanos , Macrófagos/inmunología , Macrófagos/ultraestructura , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica , Monocitos/inmunología , Monocitos/ultraestructura , Vacuolas/microbiología
13.
J Immunol ; 130(5): 2121-6, 1983 May.
Artículo en Inglés | MEDLINE | ID: mdl-6220082

RESUMEN

C-reactive protein (CRP), a trace serum protein that increases markedly in concentration during inflammatory reactions, was recently shown to bind to a subset of human IgG-FcR-bearing peripheral blood lymphocytes in the presence of a ligand such as pneumococcal C-polysaccharide (CPS). CRP has also been detected on a small percentage of PBL that are associated with NK activity. In the present study, we assessed the effects of CRP and CRP-CPS complexes on a variety of human lymphocyte functions in vitro. CRP and CRP complexes significantly enhanced (generally two to threefold) cell-mediated cytotoxicity, minimally enhanced the MLC reaction, and induced a small but regularly detectable blastogenic response in resting PBL. CRP or CRP-CPS complexes had no effect on mitogen-induced blastogenesis, PWM-induced generation of IgM plaque-forming cells, E-rosette formation, antibody-dependent cell-mediated cytotoxicity, or NK activity. The basis for the preferential ability of CRP to enhance cytotoxicity responses in vitro is under further investigation.


Asunto(s)
Proteína C-Reactiva/inmunología , Linfocitos/inmunología , Citotoxicidad Celular Dependiente de Anticuerpos , Células Productoras de Anticuerpos/inmunología , Complejo Antígeno-Anticuerpo , Citotoxicidad Inmunológica , Técnica de Placa Hemolítica , Humanos , Inmunidad Celular , Inmunoglobulina M/biosíntesis , Activación de Linfocitos , Prueba de Cultivo Mixto de Linfocitos , Polisacáridos Bacterianos/inmunología , Formación de Roseta
14.
J Exp Med ; 157(1): 301-11, 1983 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-6848619

RESUMEN

Functional NK activity can be removed from human PBL and from phagocyte- and T cell-depleted LGL preparations by treatment with antisera specific for C-reactive protein (CRP) in the presence of complement (C). Pretreatment of NK effector cells with high concentrations of anti-CRP in the absence of C also depletes functional activity. These results indicate that CRP or an antigenically similar molecule is present on a population of NK effector cells. Fluorescent antibody studies in which biotin-avidin amplification was used confirm the presence of surface CRP (S-CRP) on a small percentage of nonphagocytic peripheral blood mononuclear cells. S-CRP readily caps off, which suggest that removal by capping obviates killing by this cell population. This indicates that S-CRP or a molecule that co-caps with S-CRP may be required for successful effector-target cell interaction. The addition of exogenous CRP or CRP-CPS complexes, however, does not alter NK responses. A subpopulation of lymphoid cells responsible for functional NK activity therefore appears to bear surface CRP.


Asunto(s)
Proteína C-Reactiva/inmunología , Citotoxicidad Inmunológica , Células Asesinas Naturales/inmunología , Membrana Celular/inmunología , Células Cultivadas , Proteínas del Sistema Complemento/inmunología , Humanos , Recubrimiento Inmunológico
15.
Ann N Y Acad Sci ; 389: 274-85, 1982.
Artículo en Inglés | MEDLINE | ID: mdl-7046581

RESUMEN

The interactions between CRP and peripheral blood lymphocytes were investigated. CRP, in the presence of an appropriate ligand, bound saturably to a small percentage of normal PBL. The characteristics and optimal conditions for this binding were defined using several different assay systems. CRP was found to bind preferentially to cells with the IgG FcR. Binding was increased in the presence of acute phase sera, and higher numbers of cells binding CRP were observed in acute phase individuals. CRP and CRP-CPS had minimal effects upon lymphocyte responsiveness in vitro, although enhancing effects on MLC and CMC reactions, and a slight blastogenic effect, were observed. CRP antigenicity was detected on a small percentage of PBL, and treatment of PBL with anti-CRP and complement led to loss of NK reactivity, suggesting a possible association of CRP with this function. The functional expression of binding of CRP complexes, the relationship of the CRP-binding site to surface CRP antigenicity and the FcR, and the role of these factors in lymphocyte functions such as NK reactivity and recognition, are yet to be determined.


Asunto(s)
Proteína C-Reactiva/metabolismo , Linfocitos/metabolismo , Animales , Antígenos , Línea Celular , Humanos , Inmunoglobulina G/metabolismo , Recubrimiento Inmunológico , Células Asesinas Naturales/metabolismo , Ligandos , Unión Proteica , Receptores Fc/metabolismo
16.
Transplantation ; 32(5): 409-14, 1981 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-6977213

RESUMEN

Previous evidence has shown that Lyt-1+ helper T cells are required for an in vitro cytotoxic T cell response. We now present evidence which demonstrates an in vivo requirement for Lyt-1+ helper T cells in the activation of a killer T cell response. An adoptive transfer system was designed in which alloantigen-primed parental helper cells were transferred to an F1 recipient. After 1 day, this recipient of primed helper cells was lethally irradiated and normal responder spleen cells syngeneic to the primed helper cells were injected into the F1 recipient. In these experiments the semiallogeneic cells of the irradiated F1 mouse serve as the source of stimulator cells. When responder cells and irradiated helper cells were both present in the F1 mouse, good cytotoxic T cell responses were obtained. When either responders alone or helpers alone were examined, cytotoxic T cell responses were much lower. The presence in vivo of suppressor cells which inhibit cytotoxic T cell responses made it necessary to culture spleen cells from these irradiated recipients for short periods in vitro to reveal the cytotoxic T cells which had been generated in vivo. Cell collaboration was shown to occur before this in vitro culture period commenced; the generation of cytotoxicity required that helper cells and killer cell precursors interact in vivo. Treatment of the primed helper cells with anti-Thy-1 serum plus complement or anti-Lyt-1+ serum and complement removed helper cell activity. This indicates that the primed helper cell in in vivo collaboration is a Lyt-1+ T lymphocyte.


Asunto(s)
Antígenos Ly/inmunología , Citotoxicidad Inmunológica , Isoantígenos/inmunología , Células Asesinas Naturales/inmunología , Linfocitos T/inmunología , Animales , Femenino , Cooperación Linfocítica , Masculino , Ratones , Ratones Endogámicos BALB C/inmunología , Ratones Endogámicos CBA/inmunología , Bazo/inmunología
18.
J Exp Med ; 148(6): 1579-91, 1978 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-309924

RESUMEN

Antigen-specific helper T cells are required in the generation of cytotoxic T cells from thymocyte precursors. We have demonstrated that these alloantigen-specific helper cells can be generated in vitro and that both the quantity and quality of the helpers appear to be superior to the help obtained from unprimed spleen cells. Optimal helper cell activity is produced at day two of culture when CBA splenic helper precursors are stimulated by irradiated allogeneic spleen cells. Helper cell precursors are antigen-specific cells which cannot be instructed to express forbidden receptor specificities and bear theta antigen on their surface. The helper effectors are radioresistant, theta-bearing, and antigen-specific cells.


Asunto(s)
Citotoxicidad Inmunológica , Cooperación Linfocítica , Linfocitos T/inmunología , Animales , Antígenos , Adhesión Celular , Diferenciación Celular , Células Cultivadas , Memoria Inmunológica , Isoantígenos/análisis , Cinética , Ratones , Nylons , Bazo/inmunología , Linfocitos T/citología
20.
J Exp Med ; 145(5): 1237-49, 1977 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-300781

RESUMEN

Concanavalin A stimulation of T-cell cytotoxicity has been shown to be absolutely dependent on helper T-cell collaboration. Thymocytes stimulated with ConA do not differentiate to yield cytotoxic effector cells. However, thymocytes cocultured with irradiated spleen cells as helpers and ConA yield high levels of cytotoxicity. The helper cell bears theta antigens on its surface, is not an adherent cell, and does not require any adherent cell functions in our culture conditions. The ConA-dependent helper cells appear to be polyclonal in specificity. Thus, polyclonal stimulation of cytotoxicity by ConA requires T helper-T precursor collaboration in analogy to antigen-specific T helper-T precursor interactions. Unlike the antigen-specific interacitons, the ConA-driven cytotoxicity does not appear to require linked associative recognition for induction of cytotoxicity.


Asunto(s)
Activación de Linfocitos , Linfocitos T/inmunología , Animales , Células Productoras de Anticuerpos , Células Cultivadas , Células Clonales , Concanavalina A/farmacología , Pruebas Inmunológicas de Citotoxicidad , Relación Dosis-Respuesta Inmunológica , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos CBA , Mitógenos , Bazo/inmunología , Timo/inmunología , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA